Wordt geladen...
Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
PURPOSE: The long-term risk of prostate cancer–specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread prostate-specific antigen (PSA) screening. Models that predict the risk of PCSM are needed for patient counseling and clinical trial de...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3651598/ https://ncbi.nlm.nih.gov/pubmed/19636023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.2501 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|